Research Development Committee Webinar – Key Elements for Successful Clinical Research (2024)-WEB01-2024

Video Transcription

Video Summary

In this webinar, various experts provided insights into key elements for successful clinical research. Rebecca Rocco Penner from UC San Diego emphasized inclusivity in the team effort for research, encouraging active participation and questions. Dr. Janet Erie from the NCI discussed understanding funding opportunity announcements such as RFAs, NOFOs, and PARs, detailing how to identify and apply for research funding using available resources, emphasizing the role of program staff in shaping research agendas through community engagement.<br /><br />Dr. Ruth Carlos from the University of Michigan addressed the importance of diversity in clinical trials, noting that evidence from trials must represent broader populations to ensure generalizability. She detailed barriers to participation, including financial and logistical challenges, and discussed solutions such as offering direct payments and minimizing participants' burdens through trial design adjustments.<br /><br />Elodia Cole from the American College of Radiology focused on strategies for successful enrollment in clinical studies, spotlighting the TMIST trial's recruitment tactics. She highlighted the importance of site communication, patient understanding of trial involvement, and leveraging existing community relationships. She advised on efficient participant retention strategies and adapting methods during challenges like the COVID-19 pandemic.<br /><br />The session concluded with a Q&A, exploring topics like additional resources for early-stage investigators and strategies for enrolling diverse populations, emphasizing maintaining engagement through technological access and leveraging local support to enhance clinical trial participation.

Keywords

clinical research

inclusivity

funding opportunities

diversity

clinical trials

participant recruitment

community engagement

trial design

patient retention

COVID-19 challenges

early-stage investigators